• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Advisory Board

Protai Raises $20M to Build an Oncology Drug Discovery Pipeline

by Syed Hamza Sohail 03/15/2023 Leave a Comment

Protai Raises $20M to Build an Oncology Drug Discovery Pipeline

What You Should Know: - Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, today announced a $12 million extension of its seed round, bringing the total amount to $20M. - The round includes existing investors Grove Ventures and Pitango Healthcare and was joined by Copenhagen-based Maj Invest Equity Fund. The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data
Read More

Biden Admin Builds on Cancer Moonshot with 13 More Initiatives

by Syed Hamza Sohail 02/06/2023 Leave a Comment

Biden Admin Builds on Cancer Moonshot with 13 More Initiatives

What You Should Know: - One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today. - The Cancer Moonshot has spurred tremendous action across the federal government and from the public and private
Read More

Why ML Monitoring is Essential to AI Success in Healthcare

by Krishnaram Kenthapadi, Chief Scientist at Fiddler AI 01/10/2023 Leave a Comment

Why ML Monitoring is Essential to AI Success in Healthcare

Artificial intelligence (AI) adoption in the healthcare sector has grown significantly over the last decade, with no signs of slowing down. According to a 2021 report from HIMSS, 62% of clinicians are interested in using AI/ML tools.  From front-line workers to back-office staff, every stakeholder in the healthcare continuum can leverage AI technology to enhance healthcare quality. In fact, ML models are already being used to collect and analyze patient data at scale, thereby allowing
Read More

Exec Hires: Former CVS Health Leader Joins Virgin Pulse as Chief Medical Officer

by Executive Hires 01/10/2023 Leave a Comment

Exec Hires: Former CVS Health Leader Joins Virgin Pulse as Chief Medical Officer

What You Should Know: - Virgin Pulse, a global digital-first health, wellbeing, and navigation company, announced that Jeffrey Jacques, MD, has joined the company as Chief Medical Officer. - As chief medical officer at Virgin Pulse, Dr. Jacques will advance the company’s clinical strategy, providing insight and guidance to product and commercial teams. He will also lead the company’s Science Advisory Board, which helps ensure that Virgin Pulse’s technology and the experiences it supports
Read More

Why We Need Deflection to Reduce Overdose Deaths (and Drug Diversion) in 2023

by Susan Weinstein, President of the Legislative Analysis and Public Policy Association 01/06/2023 Leave a Comment

Why We Need Deflection to Reduce Overdose Deaths (and Drug Diversion)

The United States is still reeling from a devastating opioid epidemic. The Centers for Disease Control and Prevention (CDC) report that death from drug overdoses reached just under 108,000 between 2020 and 2021. That is enough to fill over four professional baseball stadiums.  This staggering number of overdose deaths is due to many factors, including the sale of counterfeit medications and illegal drugs that often contain deadly doses of illicitly manufactured fentanyl and other
Read More

EMRs Are Outdated, but Big Tech Is Not The Answer

by Dr. Roya Azadi, MD - Internal Medicine Specialist in Austin, TX 12/13/2022 Leave a Comment

EMRs Are Outdated, but Big Tech Is Not The Answer

Over a decade ago, the “meaningful use” clause in the United States Affordable Care Act incentivized Electronic Medical Record (EMR) adoption. The purpose of this directive was to improve the transfer of laboratory data to point-of-care clinicians to help us make better, more informed decisions for our patients. In the years that followed, EMR systems have proliferated globally; countries like New Zealand, Norway, and the Netherlands are reporting EMR usage rates above 90% for primary care
Read More

AI Improving the Patient Experience of Cancer Care

by Chris Cashwell, CEO and Founder of Azra AI 12/05/2022 Leave a Comment

AI Improving the Patient Experience of Cancer Care

For cancer patients and their loved ones, days, weeks, and months matter. In fact, anyone who has waited anxiously for test results or a treatment regimen to begin can attest that hours, or even minutes, will drag on with emotional heaviness. From a clinical standpoint as well, time to treatment significantly impacts outcomes. All suspected cancers should be ruled out or confirmed with a diagnosis so treatment can begin as soon as possible. Similarly, patients with incidental findings—masses or
Read More

Northwell Holdings & Aegis Ventures Form FemTech Company for Menopause Support

by Jasmine Pennic 11/10/2022 Leave a Comment

Northwell Holdings & Aegis Ventures Form FemTech Company for Menopause Support

What You Should Know: - Northwell Holdings and Aegis Ventures inked an agreement today for the formation of Upliv, a femtech-based women's virtual care startup that aims to raise the bar for clinical menopause support. - Upliv is the joint creation of Aegis Ventures and Northwell Holdings, the for-profit investment arm of Northwell Health. In April 2022, Aegis Ventures announced the intention to invest at least $100M in seed-stage funds toward the development of joint ventures with
Read More

SURGE Therapeutics Raises $26M to Accelerate Intraoperative Immunotherapy

by Syed Hamza Sohail 10/18/2022 Leave a Comment

SURGE Therapeutics Raises $26M to Accelerate Intraoperative Immunotherapy

What You Should Know: - SURGE Therapeutics (SURGE) recently announced the completion of a $26 million Series A financing led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, and the Cancer Research Institute. - The funds will be used to accelerate the development of the SURGE™ intraoperative immunotherapy approach, expand the team, and initiate clinical trials for its injectable biodegradable hydrogel. Using
Read More

Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies

by Syed Hamza Sohail 09/20/2022 Leave a Comment

Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies

What You Should Know: - Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M in Series A financing to pioneer novel therapies to modulate mitochondrial function. - The financing was led by ARCH Venture Partners and Mubadala Capital with participating investors HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, and
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |